ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
0.00%
Dow Jones
37,903.29
0.00%
US Dollar vs MXN
16.95635
0.08%
Brent Oil
83.625
0.10%
Bitcoin
58,757.08
0.89%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) Noticias

ABT Abbott Laboratories

106.49
0.20 (0.19%)
Pre Mercado
Última actualización: 08:10:29
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Abbott Laboratories ABT NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.20 0.19% 106.49 08:10:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
106.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202408:00PRNUSAbbott's Breakthrough Dissolving Stent Receives FDA Approval..
17/4/202410:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
17/4/202406:30PRNUSAbbott Reports First-Quarter 2024 Results and Raises..
17/4/202405:59IHMARKETNEWSUS Index Futures See Gains, Oil Prices Dip
03/4/202406:12IHMARKETNEWSCal-Maine Surges on Strong Quarterly Performance, Taiwan..
02/4/202408:00PRNUSAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind..
01/4/202408:00PRNUSAbbott Receives FDA Clearance for Whole Blood Rapid Test to..
27/3/202415:30PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
19/3/202407:00PRNCAUne première au Canada -- Abbott fait progresser le..
06/3/202408:00PRNUSReal-World Data Show Abbott's FreeStyle Libre® Systems and..
04/3/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:45EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:32EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:22EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:02EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202409:19PRNUSAbbott Declares 401st Consecutive Quarterly Dividend
13/2/202417:47PRNUSFDA Advisory Committee Votes in Favor of Abbott's..
13/2/202415:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202404:31IHMARKETNEWSSantander’s Stock Declines Amid Sanctions Evasion Scandal,..
01/2/202408:00PRNUSNew Study Shows Mixed Reality Technology for Blood Donation..
31/1/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:00PRNUSAbbott Launches New PROTALITY™ Brand to Support Adults on..
29/1/202415:10EDGAR2Form 8-K - Current report
29/1/202415:04EDGAR2Form 144 - Report of proposed sale of securities
26/1/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202408:00PRNUSAbbott Launches World's Smallest Rechargeable System With..

Su Consulta Reciente

NYSE
ABT
Abbott Laboratories
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados